Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06856720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NMES, Exercise, and Glycemic Control in Older Adults With Type 2 Diabetes

Study acronym: NMES4GlyCon
StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Aug 30, 2026 → Oct 30, 2026
See other at-risk trials from University of Salamanca

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 30, 2026 to Oct 30, 2026v5
  2. Lead sponsor: Carlos Tavares to University of Salamancav4 Show 12 more changesShow less
    • Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of May 1, 2025 to Oct 27, 2025
    • Primary endpoints: 2 to 1
    • Enrollment target: 105 to 75
    • Study sites: 0 to 1
    • Primary and study completion dates: May 1, 2026 to Aug 30, 2026
    • Interventions: Aerobic and resistance exercise (Behavioral), Health literacy education (Behavioral), Neuromuscular Electrical Stimulation (NMES) (Device) to Combined Aerobic and Resistance Exercise (Behavioral), Health Literacy Education (Behavioral), Neuromuscular Electrical Stimulation (Device)
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: 3 to 5
    • Study description shortened, about 35 words
    • Collaborators shortened, about 13 words
    • Study title shortened, about 5 words
  3. Study Identification, Study Statusv3
  4. Lead sponsor: University of Salamanca to Carlos Tavares
    • Secondary endpoints: details revised at 2 of 3 entries
    • Collaborators: 1 to 3
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Salamanca
45 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
Adults aged 60 years and older with type 2 diabetes living in nursing homes may experience difficulty participating in conventional exercise programs because of frailty, mobility limitations, or chronic health conditions. This randomized controlled trial compares three 12-week non-pharmacological interventions for glycemic management: neuromuscular electrical stimulation (NMES), supervised combined aerobic and resistance exercise, and a structured health literacy intervention. Participants will be randomly assigned to one of the three groups. The primary outcome is weekly mean fasting capillary glucose. Secondary outcomes include health-related quality of life, treatment satisfaction, adherence, and safety. The study aims to identify feasible and clinically relevant strategies for improving diabetes management in institutionalized older adults.
Trial Details
NCT Number NCT06856720
Lead Sponsor University of Salamanca
Conditions
(from sponsor)		 Type 2 Diabetes Mellitus, Hyperglycemia Due to Type 2 Diabetes Mellitus, Aging
Related terms Diabetes Mellitus, Type 2
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov